Stay updated on Pembrolizumab in ER+/HER2- Breast Cancer Clinical Trial.

Sign up to get notified when there's something new on the Pembrolizumab in ER+/HER2- Breast Cancer Clinical Trial. page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab in ER+/HER2- Breast Cancer Clinical Trial. page

  1. Check
    4 days ago
    Change Detected
    Summary
    The website has been updated from version 2.11.0 to 2.11.2, indicating new features or improvements in the latest release.
    Difference
    0.0%
    Check dated 2024-10-03T05:48:29.000Z thumbnail image
  2. Check
    12 days ago
    Change Detected
    Summary
    The website has been updated to Revision v2.11.0, while the previous version v2.10.5 has been removed, along with a notice regarding delays in study record information.
    Difference
    0.3%
    Check dated 2024-09-25T23:29:57.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    ClinicalTrials.gov is addressing delays in displaying study record information, and the site has been updated to version 2.10.5, replacing the previous version 2.10.3.
    Difference
    0.3%
    Check dated 2024-09-18T17:30:29.000Z thumbnail image
  4. Check
    26 days ago
    No Change Detected
  5. Check
    33 days ago
    Change Detected
    Summary
    The website has been updated from version 2.10.2 to 2.10.3, indicating a new release.
    Difference
    0.0%
    Check dated 2024-09-04T06:19:45.000Z thumbnail image
  6. Check
    55 days ago
    Change Detected
    Summary
    The website has been updated from version 2.10.0 to 2.10.2, indicating new features or improvements.
    Difference
    0.0%
    Check dated 2024-08-14T00:56:00.000Z thumbnail image
  7. Check
    76 days ago
    Change Detected
    Summary
    The website has been updated to version v2.10.0, adding 6 more interventions/treatments, 5 more study numbers, and noting that the study now has 244 locations, while the previous version v2.9.7 has been removed.
    Difference
    0.2%
    Check dated 2024-07-23T14:50:19.000Z thumbnail image

Stay in the know with updates to Pembrolizumab in ER+/HER2- Breast Cancer Clinical Trial.

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in ER+/HER2- Breast Cancer Clinical Trial. page.